BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Familiar Branded Drugs Top List of Medicines with Recent Price Hikes

  Prescription drug costs have continued to rise, with more than 150 drug manufacturers raising their prices in January.

  February 21, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Homology PKU Therapy Hit with Latest Trial Hold

  The FDA asked Homology Medicines to modify the pheNIX gene therapy trial’s risk mitigation measures to prevent any serious issues that may arise.

  February 21, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  The Debate: Should Gene Editing Be Used to Make Better Babies?

  BioSpace covers the Intelligence Squared U.S. debate: Will gene editing enable a healthier, more diverse, more equitable population, or will it create market-born eugenics and a dystopian society?

  February 21, 2022

   · 

  5 min read

   · 

  Gail Dutton
• 

  Policy

  COVID-19 Update: Novavax EUA Expected, Toddler Vaccine Delay

  It was noted early in the COVID-19 pandemic that the disease was peculiar — not only was it a respiratory disease, but it created hyper-immune responses.

  February 21, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  New Data Supports Enhertu’s Benefit in HER2 Low Breast Cancer

  AstraZeneca and Daiichi Sankyo released positive data from their Phase III trial of Enhertu. An alternative to chemotherapy for some HER2 low breast cancer.

  February 21, 2022

   · 

  2 min read

   · 

  Rosemary Scott
• 

  Biotech Bay

  New Research Offers Hope for Treating Congenital Heart Defects

  Researchers may have found a potential treatment for congenital heart defects in a surprising source: an over-the-counter cough suppressant. Know more here.

  February 21, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Biotech Beach

  Basepaws’ Cat DNA Kit Warns of Pending Diseases and Defines Breed

  “We were founded on the premise of felines first, and have been called ‘23andMeow,’ Anna Skaya, founder and CEO, told BioSpace.

  February 21, 2022

   · 

  5 min read

   · 

  Gail Dutton
• 

  Lone Star Bio

  Breakthroughs in Heart Attack Research Paves Way for Potential Gene Therapy

  A new project uncovering genetic changes linked to damage following a heart attack could potentially pave the way for gene therapies to prevent long-term cell damage.

  February 21, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Career Advice

  How to Get Your First Job After College in the Life Sciences

  Learn the best tips, tricks, and practices to help yourself to get the first job after college life sciences industry right out of college in our comprehensive guide.

  February 21, 2022

   · 

  4 min read

   · 

  Hannah Harshman
• Business

  Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer

  Biosion, Inc., a global clinical stage biotechnology company, announced the appointment of Joel Edwards as chief business officer.

  February 21, 2022

   · 

  3 min read